FDA Adverse Event Malfunction Summary report: N

GALAXY SYSTEM

MDR report key: 23154483 · Received September 26, 2025

Report

Report Number
3021325287-2025-00019
Event Type
Malfunction
Date Received
September 26, 2025
Date of Event
August 21, 2024
Report Date
September 26, 2025
Manufacturer
NOAH MEDICAL CORP.
Product Code
EOQ
PMA / PMN Number
K223144
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
003

Narratives

Additional Manufacturer Narrative · 0

SYSTEM AND BRONCHOSCOPE MANUFACTURING RECORDS WERE REVIEWED AND FOUND NO ISSUES ASSOCIATED WITH THIS CASE. FAILURE ANALYSIS WAS NOT PERFORMED AS THE SCOPE WAS NOT RETURNED. RECORDS CONFIRM THAT IT PASSED ALL FINAL QA/QC TESTING. VIDEO REVIEW SHOWED NO MALFUNCTIONS OR USE ERRORS. AT 11:29, THE PHYSICIAN MAY HAVE ARTICULATED INTO THE PARENCHYMA; AT 12:10, IRRIGATION WAS APPLIED TO WHAT APPEARED TO BE AN AIRWAY TEAR BEFORE RETRACTING. THE PROCEDURE CONTINUED WITH MULTIPLE BIOPSIES, WITH MINOR BLEEDING INTERMITTENTLY MANAGED BY SALINE, AND ENDED WITH SCOPE RETRACTION TO CHECK FOR RESIDUAL BLEEDING. ALTHOUGH THE PHYSICIAN SUGGESTED THE SCOPE TIP DESIGN CAUSED THE AIRWAY TEAR, THE BLEEDING WAS EFFECTIVELY MANAGED WITH IRRIGATION ALONE, AND NO FURTHER INTERVENTION WAS NEEDED. WITH THE SCOPE DISCARDED, PHYSICAL INSPECTION WAS NOT POSSIBLE, BUT QA/QC CONFIRMED THE DEVICE MET SPECIFICATIONS. THE INJURY IS MORE CONSISTENT WITH THE KNOWN INHERENT RISKS OF BRONCHOSCOPY. THE COMPLAINT IS BEING REPORTED BASED ON THE FOLLOWING CONCLUSIONS: DURING A GALAXY-ASSISTED BIOPSY PROCEDURE, THE PATIENT SUSTAINED AN AIRWAY TEAR AND EXPERIENCED BLEEDING. THE BLEEDING WAS CONTROLLED WITH IRRIGATION, AND NO FURTHER INTERVENTION WAS REQUIRED. THE PHYSICIAN ATTRIBUTES THE INJURY TO THE SCOPE TIP.

Description of Event or Problem · 0

AN AIRWAY (BRONCHIAL) TEAR AND BLEEDING WAS REPORTED WHILE THE PATIENT WAS UNDERGOING A GALAXY-ASSISTED BIOPSY PROCEDURE. THE INJURY OCCURRED DURING GUIDED NAVIGATION THROUGH A PERIPHERAL AIRWAY. THE USER WAS NAVIGATING NORMALLY, AND A TEAR WAS OBSERVED PRIOR TO SAMPLING. AFTERWARDS, BLEEDING WAS OBSERVED FOLLOWING SAMPLING, WHICH WAS MANAGED WITH SALINE. THERE WERE NO FURTHER INTERVENTIONS, COMPLICATIONS, OR MALFUNCTIONS REPORTED. ATTEMPTS TO COLLECT PATIENT DEMOGRAPHICS WERE UNSUCCESSFUL.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
282271 GALAXY SYSTEM GALAXY SYSTEM EOQ NOAH MEDICAL CORP. GALB-001 2024070302

Patients

Seq Age Sex Outcome Treatment
1 83 YR Female